. Author manuscript; available in PMC: 2010 Oct 14.

Published in final edited form as: Clin Exp Metastasis. 2010 Jun 6;27(7):481–491. doi: 10.1007/s10585-010-9337-9

Table 1.

Phospho-Pak1 immunostaining results in medulloblastoma (MB)

	Negative	Positive	Positive (%)
Histologic subtype
Classic	11	14	56
Anaplastic	10	14	58
Desmoplastic	10	11	52
N/A^a	13	11	46
Total	44	50	53
Non-metastatic	41	45	52
Metastatic	3	5	62
Deceased	2	9	82
Survived^b	18	5	22^*

Histologic subtype of the tumors of deceased = classic (3), anaplastic (1), desmoplastic (2), N/A (5) and subtype of tumors of survived = classic (4), anaplastic (3), desmoplastic (6), N/A (10)

Not able to confirm subtype of MB

Alive without disease recurrence or progression >5 years from the end of initial treatment

P < 0.001, comparing positive % phospho-Pak1 tumors between deceased and survived